| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 10/14/2004 | US20040204410 Such as 1-(4,5-Bis-(4-chloro-phenyl)-2-(2,4-dimethoxy-phenyl)-4,5-dihydro-imidazol-1-yl)-2-methyl-propan-1-one which inhibits the interaction of MDM2 protein with p53-like peptide; antiproliferative agents |
| 10/14/2004 | US20040204408 Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 10/14/2004 | US20040204397 Calcitonin gene related peptide receptor antagonists |
| 10/14/2004 | US20040204386 for uses such as inhibiting the activity of lysophosphatidic acid acyltransferase beta and/or inhibiting the proliferation of a cell (e.g., tumor cell) |
| 10/14/2004 | US20040204317 fluorescein dyes that exhibit a first color when in the crystal structured form and a second color when in the liquid, amorphous form, for use in thermal printing |
| 10/14/2004 | US20040204257 System for and a method of manufacturing personal golf putters |
| 10/14/2004 | US20040202624 Galenical formulation |
| 10/14/2004 | DE10315573A1 Substituierte Pyrazole Substituted pyrazoles |
| 10/14/2004 | DE10315572A1 Substituierte Pyrazole Substituted pyrazoles |
| 10/14/2004 | DE10315571A1 Pyrazolverbindungen Pyrazole |
| 10/14/2004 | DE10315569A1 Substituierte Pyrazolverbindungen Substituted pyrazole |
| 10/14/2004 | DE10315377A1 New carbonyl-substituted carbocyclic or heterocyclic compounds, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors |
| 10/14/2004 | DE10315285A1 Chromenonindole Chromenonindole |
| 10/14/2004 | CA2521172A1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 10/14/2004 | CA2520896A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 10/14/2004 | CA2520724A1 Benzopyran compounds useful for treating inflammatory conditions |
| 10/14/2004 | CA2520686A1 Therapeutic and/or preventive agent for pulmonary disease |
| 10/14/2004 | CA2520577A1 Pharmaceutical composition |
| 10/14/2004 | CA2520377A1 Migrastatin analog compositions and uses thereof |
| 10/14/2004 | CA2520281A1 Benzimidazole derivatives and their use for modulating the gabaa recept or complex |
| 10/14/2004 | CA2519899A1 Ophthalmic compositions for treating ocular hypertension |
| 10/14/2004 | CA2519291A1 Chromene derivatives as anti-inflammatory agents |
| 10/14/2004 | CA2518913A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 10/13/2004 | EP1466906A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/13/2004 | EP1466904A1 Biaryl compound and use thereof |
| 10/13/2004 | EP1466902A1 Androgen receptor antagonists |
| 10/13/2004 | EP1466899A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
| 10/13/2004 | EP1466603A2 Novel catechols as antimicrobial agents |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465872A1 4-sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 10/13/2004 | EP1465869A1 Modulators of lxr |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465865A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 10/13/2004 | EP1465638A2 Phosphate transport inhibitors |
| 10/13/2004 | EP1465635A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 10/13/2004 | EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1465619A1 Suppression of cartilage degradation via the estrogen receptor |
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1250095B1 Versatile hydrophilic dyes |
| 10/13/2004 | EP1187831B1 Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 10/13/2004 | EP1150954B1 Anti-imflammatory indole derivatives |
| 10/13/2004 | EP1102763B1 Fsh mimetics for the treatment of infertility |
| 10/13/2004 | EP1097142B1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | EP1005458B1 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation |
| 10/13/2004 | EP0986389B1 Novel process |
| 10/13/2004 | EP0736036B1 Kininogen inhibitors |
| 10/13/2004 | CN1537108A Iodobenzopyrran-4-one derivatives having fungicidal activity |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537101A Pyridine matrix metalloproteinase inhibitors |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1535966A Indazole derivative for pestide |
| 10/13/2004 | CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound |
| 10/13/2004 | CN1535956A Substituted phenyl keto-enol pesticide and weedicide |
| 10/13/2004 | CN1170827C Benzofurylpyrone deriuvatives |
| 10/13/2004 | CN1170822C Imidazole compounds and medicinal use thereof |
| 10/13/2004 | CN1170819C Piperidine alcohols |
| 10/12/2004 | US6803380 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 10/12/2004 | US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc |
| 10/12/2004 | US6803374 Compounds useful for treating hepatitis C virus |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803364 Il-5 inhibiting 6-azauracil derivatives |
| 10/12/2004 | US6803129 Organic light emitting diode and organic luminescent materials thereof |
| 10/12/2004 | CA2132098C Antimicrobial imidazoles for regulating the greasiness of the skin |
| 10/07/2004 | WO2004085427A1 Enantioselective hydrogenation of intermediates during tipranavir synthesis |
| 10/07/2004 | WO2004085418A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 10/07/2004 | WO2004085409A2 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof |
| 10/07/2004 | WO2004085408A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 10/07/2004 | WO2004085406A1 Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 10/07/2004 | WO2004085403A1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 10/07/2004 | WO2004085401A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | WO2004085392A1 Melatonin derivatives and their use for treating neurological dysfunctions |
| 10/07/2004 | WO2004085385A2 Cannabinoid receptor ligands |
| 10/07/2004 | WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 10/07/2004 | WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | WO2004084813A2 Chemical compounds |
| 10/07/2004 | WO2004084634A1 N-phenyl- ‘ (4-pyridyl)- azinyl!amine derivatives as plant protection agents |
| 10/07/2004 | WO2004075823A3 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 10/07/2004 | WO2004074276B1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 10/07/2004 | WO2004046105A3 Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids |
| 10/07/2004 | WO2004026829A3 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibitors |
| 10/07/2004 | WO2003068757A9 Novel pyridin- and pyrimidin-derivatives |
| 10/07/2004 | US20040198986 Chemical compounds |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198802 Antiproliferative agents |
| 10/07/2004 | US20040198799 Methods of increasing endogenous testosterone levels |
| 10/07/2004 | US20040198790 Triazole compound containing a phosphonate group |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198771 medical equipment for angioplasty |
| 10/07/2004 | US20040198757 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/07/2004 | US20040198750 Compositions useful as inhibitors of protein kinases |
| 10/07/2004 | US20040198749 Methods of using sodium channel blockers |
| 10/07/2004 | US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders |